Rocket Pharmaceuticals Inc buy BiotechBee
Start price
26.10.22
/
70%
€17.96
Target price
31.12.24
€28.00
Performance (%)
15.29%
End price
08.06.24
€20.70
Summary
This prediction ended on 08.06.24 with a price of €20.70. The BUY prediction by BiotechBee finished with a performance of 15.29%. BiotechBee has a follow-up prediction for Rocket Pharmaceuticals Inc where he still thinks Rocket Pharmaceuticals Inc is a Buy. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Rocket Pharmaceuticals Inc | -0.523% | -0.523% | 35.591% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to BiotechBee what are the pros and cons of Rocket Pharmaceuticals Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Rocket Pharmaceuticals Inc diskutieren
Buy mit Kursziel 28,0
In the thread Trading Rocket Pharmaceuticals Inc
Buy beendet
Current prediction by BiotechBee for Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€20.70
08.06.24
08.06.24
€32.00
31.01.26
31.01.26
-27.75%
04.10.24
04.10.24
Could be very worthwhile Investment >20% year